Novartis/Orion Comtan Enters COMT Field Without Liver Warnings
Novartis will launch Comtan into the catechol-O-methyltransferase inhibitor class without warnings concerning hepatic toxicity.
Novartis will launch Comtan into the catechol-O-methyltransferase inhibitor class without warnings concerning hepatic toxicity.